In the article titled “Chaperone-Mediated Autophagy Markers LAMP2A and HSC70 Are Independent Adverse Prognostic Markers in Primary Resected Squamous Cell Carcinomas of the Lung” [1], the authors identified an error in the name of the manufacturer of the antibody mentioned in Materials and Methods. The following should be corrected from “LAMP2A (Novus Biologicals, Zug, Switzerland, rabbit polyclonal, #NB600-1384) HSC70 (LabForcembl, Nunningen, Switzerland, rabbit polyclonal, #PM0045)” to “LAMP2A (Abcam, Cambridge, UK, rabbit polyclonal, ab18528) HSC70 (Thermo Fisher Scientific, Waltham, MA, USA, mouse monoclonal, MA3-014).
Corrigendum to "Chaperone-Mediated Autophagy Markers LAMP2A and HSC70 Are Independent Adverse Prognostic Markers in Primary Resected Squamous Cell Carcinomas of the Lung"
Schmid, Ralph A;
2021-01-01
Abstract
In the article titled “Chaperone-Mediated Autophagy Markers LAMP2A and HSC70 Are Independent Adverse Prognostic Markers in Primary Resected Squamous Cell Carcinomas of the Lung” [1], the authors identified an error in the name of the manufacturer of the antibody mentioned in Materials and Methods. The following should be corrected from “LAMP2A (Novus Biologicals, Zug, Switzerland, rabbit polyclonal, #NB600-1384) HSC70 (LabForcembl, Nunningen, Switzerland, rabbit polyclonal, #PM0045)” to “LAMP2A (Abcam, Cambridge, UK, rabbit polyclonal, ab18528) HSC70 (Thermo Fisher Scientific, Waltham, MA, USA, mouse monoclonal, MA3-014).File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.